<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34748955</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Complementary therapies in medicine</Title><ISOAbbreviation>Complement Ther Med</ISOAbbreviation></Journal><ArticleTitle>A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review.</ArticleTitle><Pagination><StartPage>102788</StartPage><MedlinePgn>102788</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ctim.2021.102788</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0965-2299(21)00129-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The coronavirus disease 2019 (COVID-19) pandemic has led to significant morbidity and mortality. Although COVID-19 vaccination is available, therapeutic options are still needed. The goal of the present manuscript is to report on a treatment strategy used in a naturopathic medical practice for mild and moderate COVID-19.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective chart review was conducted of 30 consecutive patients diagnosed with mild and moderate COVID-19 who were provided multi-nutrient, herbal, and probiotic treatment in a rural, out-patient, naturopathic primary care setting.</AbstractText><AbstractText Label="MAIN OUTCOMES MEASURES" NlmCategory="METHODS">The primary outcome was treatment safety; secondary outcomes included changes in symptoms, progression to severe COVID-19, incidence of long COVID, and recovery time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">No side effects or adverse events were reported from treatment and all patients experienced resolution of symptoms presumed to be associated with COVID-19 infection. One patient who had been ill for 28 days prior to presentation was hospitalized. Five patients had an illness duration of more than one month. Time to treatment was correlated with duration of illness post-treatment (r&#xa0;=&#xa0;0.63, p&#xa0;&lt;&#xa0;0.001) and more symptoms at presentation was correlated with a longer duration of illness (r&#xa0;=&#xa0;0.52, p&#xa0;&lt;&#xa0;0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this retrospective chart review, a multi-nutrient, herbal, and probiotic therapeutic approach for mild and moderate COVID-19 appeared to be well-tolerated. Delay in seeking treatment after symptom onset, as well as more symptoms at presentation, were correlated with a longer duration of illness. This treatment strategy may have clinical benefit, warranting prospective clinical trials with confirmed COVID-19 cases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>Melissa S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>National University of Natural Medicine, Helfgott Research Institute, 2220 SW 1st Ave, Portland, OR, United States. Electronic address: drmelissabarber@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrett</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National University of Natural Medicine, Helfgott Research Institute, 2220 SW 1st Ave, Portland, OR, United States. Electronic address: rbarrett@nunm.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradley</LastName><ForeName>Ryan D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>National University of Natural Medicine, Helfgott Research Institute, 2220 SW 1st Ave, Portland, OR, United States. Electronic address: rbradley@nunm.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Canby Clinic, 452 NW 1st Ave, Canby, OR, United States. Electronic address: drwalker@canbyclinic.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>Complement Ther Med</MedlineTA><NlmUniqueID>9308777</NlmUniqueID><ISSNLinking>0965-2299</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Case reports</Keyword><Keyword MajorTopicYN="N">Complementary therapies</Keyword><Keyword MajorTopicYN="N">Herbal medicine</Keyword><Keyword MajorTopicYN="N">Immune system</Keyword><Keyword MajorTopicYN="N">Integrative medicine</Keyword><Keyword MajorTopicYN="N">Intravenous infusions</Keyword><Keyword MajorTopicYN="N">Minerals</Keyword><Keyword MajorTopicYN="N">Naturopathic medicine</Keyword><Keyword MajorTopicYN="N">Nutrition therapy</Keyword><Keyword MajorTopicYN="N">Orthomolecular therapy</Keyword><Keyword MajorTopicYN="N">Phytotherapy</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vitamins</Keyword></KeywordList><CoiStatement>Authors M.S.B., R.B., R.D.B, and E.W. have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>8</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34748955</ArticleId><ArticleId IdType="pmc">PMC8570825</ArticleId><ArticleId IdType="doi">10.1016/j.ctim.2021.102788</ArticleId><ArticleId IdType="pii">S0965-2299(21)00129-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 dashboard. Center for Systems Science and Engineering, Johns Hopkins University; Published 2021. Accessed 5 July 2021. &#x3008;https://coronavirus.jhu.edu/map.html&#x3009;.</Citation></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;0(0):1&#x2013;18. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. Off Natl Stat. Published online 2021:1&#x2013;16.</Citation></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(April):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., Court C.A., Buxton M., Husain L. Management of post-acute covid-19 in primary care. Br Med J. 2020;370(m3026):3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Lu H. New challenges to fighting COVID-19: virus variants, potential vaccines, and development of antivirals. Biosci Trends. 2021;15(2):126&#x2013;128. doi: 10.5582/bst.2021.01092.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2021.01092</ArticleId><ArticleId IdType="pubmed">33746183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C., Tu P., Beitsch L. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines. 2020;9(1):1&#x2013;32. doi: 10.3390/VACCINES9010016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES9010016</ArticleId><ArticleId IdType="pmc">PMC7823859</ArticleId><ArticleId IdType="pubmed">33396832</ArticleId></ArticleIdList></Reference><Reference><Citation>Coustasse A., Kimble C., Maxik K. COVID-19 and vaccine hesitancy: a challenge the United States must overcome. J Ambul Care Manag. 2021;44(1):71&#x2013;75. doi: 10.1097/JAC.0000000000000360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JAC.0000000000000360</ArticleId><ArticleId IdType="pubmed">33165121</ArticleId></ArticleIdList></Reference><Reference><Citation>Achiron A., Mandel M., Dreyer-Alster S., et al. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord. 2021;14 doi: 10.1177/17562864211012835. 17562864211012836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562864211012835</ArticleId><ArticleId IdType="pmc">PMC8072850</ArticleId><ArticleId IdType="pubmed">34035836</ArticleId></ArticleIdList></Reference><Reference><Citation>Gresham L.M., Marzario B., Dutz J., Kirchhof M.G. An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology. J Am Acad Dermatol. 2021;84(6):1652&#x2013;1666. doi: 10.1016/j.jaad.2021.01.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2021.01.047</ArticleId><ArticleId IdType="pmc">PMC7816618</ArticleId><ArticleId IdType="pubmed">33482251</ArticleId></ArticleIdList></Reference><Reference><Citation>Shroff RT, Chalasani P., Wei R., et al. Immune responses to COVID-19 mRNA vaccines in patients with solid tumors on active, immunosuppressive cancer therapy. medRxiv Prepr Serv Heal Sci. Published online May 14, 2021. doi:10.1101/2021.05.13.21257129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.13.21257129</ArticleId></ArticleIdList></Reference><Reference><Citation>Agha M., Blake M., Chilleo C., Wells A., Haidar G.. Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients. medRxiv Prepr Serv Heal Sci. Published online April 7, 2021:2021.04.06.21254949. doi:10.1101/2021.04.06.21254949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.06.21254949</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarsky B.J., Werbel W.A., Avery R.K., et al. Antibody response to 2-dose sars-cov-2 mrna vaccine series in solid organ transplant recipients. J Am Med Assoc. 2021;325(21):2204&#x2013;2206. doi: 10.1001/jama.2021.7489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7489</ArticleId><ArticleId IdType="pmc">PMC8100911</ArticleId><ArticleId IdType="pubmed">33950155</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M., Chen J., Kim S., et al. Analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States. Emerg Infect Dis. 2020;26(8):1720&#x2013;1730. doi: 10.3201/eid2608.191493.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.191493</ArticleId><ArticleId IdType="pmc">PMC7392442</ArticleId><ArticleId IdType="pubmed">32348234</ArticleId></ArticleIdList></Reference><Reference><Citation>NIAID Strategic Plan for COVID-19 Research - 2021 Update. Accessed 7 July 2021. &#x3008;https://www.niaid.nih.gov/sites/default/files/NIAID-COVID-19-Strategic-Plan-2021.pdf&#x3009;.</Citation></Reference><Reference><Citation>BIO COVID-19 Therapeutic Development Tracker. Accessed July 7, 2021. &#x3008;https://www.bio.org/policy/human-health/vaccines-biodefense/coronavirus/pipeline-tracker&#x3009;.</Citation></Reference><Reference><Citation>Schiller L. COVID-19: developing drugs and biological products for treatment or prevention; guidance for industry; availability. Fed Regist. 2020;85(97):29949&#x2013;29951. doi: 10.1016/0196-335x(80)90058-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0196-335x(80)90058-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnier J.J., Kienle G., Altman D.G., Moher D., Sox H., Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep. 2013;2013 doi: 10.1136/bcr-2013-201554. bcr2013201554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2013-201554</ArticleId><ArticleId IdType="pmc">PMC3844611</ArticleId><ArticleId IdType="pubmed">24228906</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley D.S., Barber M.S., Kienle G.S., et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218&#x2013;235. doi: 10.1016/j.jclinepi.2017.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.04.026</ArticleId><ArticleId IdType="pubmed">28529185</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar M., Matthew H. The retrospective chart review: important methodological considerations. J Educ Eval Health Prof. 2013;10:12. doi: 10.3352/jeehp.2013.10.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.3352/jeehp.2013.10.12</ArticleId><ArticleId IdType="pmc">PMC3853868</ArticleId><ArticleId IdType="pubmed">24324853</ArticleId></ArticleIdList></Reference><Reference><Citation>Gearing R.E., Mian I.A., Baber J., Ickowicz A. A methodology for conducting retrospective chart review research in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry. 2006;15(3):126&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2277255</ArticleId><ArticleId IdType="pubmed">18392182</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Accessed 8 August 2021. &#x3008;https://www.covid19treatmentguidelines.nih.gov/&#x3009;.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Minor B.L., et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208. doi: 10.1016/J.JBI.2019.103208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JBI.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377&#x2013;381. doi: 10.1016/j.jbi.2008.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber M.S., Bradley R.D., Riley D.S., Tippens K.M. Testing a web-based data collection tool for clinical case reporting: NCNM-CR. Integr Med A Clin J. 2016;15(1):42.</Citation></Reference><Reference><Citation>Weeks J. Call to action: announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry. J Alter Complement Med. 2020;26(4):256&#x2013;258. doi: 10.1089/acm.2020.29083.jjw.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2020.29083.jjw</ArticleId><ArticleId IdType="pubmed">32250655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhimraj A., Morgan R., Shumaker A., et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Infectious Diseases Society of America 2021. Accessed 2 August 2021. &#x3008;https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/#toc-12&#x3009;.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197612</ArticleId><ArticleId IdType="pubmed">32338708</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard Davenport J., Fitzgerald K., Hodges R.. Bone Broth Report.; 2019. doi:10.1891/9781617052385.0096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1891/9781617052385.0096</ArticleId></ArticleIdList></Reference><Reference><Citation>Iddir M., Brito A., Dingeo G., et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020;12(6):1562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7352291</ArticleId><ArticleId IdType="pubmed">32471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G., Fang Y., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J Nutr. 2003;134:489&#x2013;492. &#x3008;http://www.ncbi.nlm.nih.gov/pubmed/14988435&#x3009;</Citation><ArticleIdList><ArticleId IdType="pubmed">14988435</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca G., Cardile V., Puglia C., Bonina C., Bonina F. Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells. Clin Exp Gastroenterol. 2012;5(1):61&#x2013;67. doi: 10.2147/CEG.S28792.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEG.S28792</ArticleId><ArticleId IdType="pmc">PMC3358810</ArticleId><ArticleId IdType="pubmed">22629114</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennard B.O., Ertl R.F., Gossman G.L., Robbins R.A., Rennard S.I. Chicken soup inhibits neutrophil chemotaxis in vitro. Chest. 2000;118(4):1150&#x2013;1157. doi: 10.1378/chest.118.4.1150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.118.4.1150</ArticleId><ArticleId IdType="pubmed">11035691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroll J.L., Werchan C.A., Rosenfield D., Ritz T. Acute ingestion of beetroot juice increases exhaled nitric oxide in healthy individuals. PLoS One. 2018;13(1):1&#x2013;11. doi: 10.1371/journal.pone.0191030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0191030</ArticleId><ArticleId IdType="pmc">PMC5784918</ArticleId><ArticleId IdType="pubmed">29370244</ArticleId></ArticleIdList></Reference><Reference><Citation>Files D.C., Heinrich T., Shields K.L., et al. A randomized pilot study of nitrate supplementation with beetroot juice in acute respiratory failure. Nitric Oxide - Biol Chem. 2020;94(October 2019):63&#x2013;68. doi: 10.1016/j.niox.2019.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2019.10.009</ArticleId><ArticleId IdType="pubmed">31669503</ArticleId></ArticleIdList></Reference><Reference><Citation>Raubenheimer K., Hickey D., Leveritt M., et al. Acute effects of nitrate-rich beetroot juice on blood pressure, hemostasis and vascular inflammation markers in healthy older adults: a randomized, placebo-controlled crossover study. Nutrients. 2017;9(11):1270. doi: 10.3390/nu9111270.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111270</ArticleId><ArticleId IdType="pmc">PMC5707742</ArticleId><ArticleId IdType="pubmed">29165355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninfali P., Angelino D. Nutritional and functional potential of Beta vulgaris cicla and rubra. Fitoterapia. 2013;89(1):188&#x2013;199. doi: 10.1016/j.fitote.2013.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fitote.2013.06.004</ArticleId><ArticleId IdType="pubmed">23751216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieli&#x144;ska-Przyjemska M., Olejnik A., Kostrzewa A., &#x15a;uczak M., Jagodzi&#x144;ski P.P., Baer-Dubowska W. The beetroot component betanin modulates ROS production, DNA damage and apoptosis in human polymorphonuclear neutrophils. Phyther Res. 2012;26(6):845&#x2013;852. doi: 10.1002/ptr.3649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.3649</ArticleId><ArticleId IdType="pubmed">22076941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J., Bing S.J., Kim A., et al. Beetroot (Beta vulgaris) rescues mice from &#x3b3;-ray irradiation by accelerating hematopoiesis and curtailing immunosuppression. Pharm Biol. 2017;55(1):306&#x2013;316. doi: 10.1080/13880209.2016.1237976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13880209.2016.1237976</ArticleId><ArticleId IdType="pmc">PMC6130760</ArticleId><ArticleId IdType="pubmed">27927068</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Zhu Y., Zhang J., Li Y., Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ. 2020;10(7):e039519. doi: 10.1136/bmjopen-2020-039519. 039519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039519</ArticleId><ArticleId IdType="pmc">PMC7348463</ArticleId><ArticleId IdType="pubmed">32641343</ArticleId></ArticleIdList></Reference><Reference><Citation>Colunga Biancatelli R.M.L., Berrill M., Catravas J.D., Marik P.E. Quercetin and Vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19) Front Immunol. 2020;11:1&#x2013;11. doi: 10.3389/fimmu.2020.01451.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01451</ArticleId><ArticleId IdType="pmc">PMC7318306</ArticleId><ArticleId IdType="pubmed">32636851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wintergerst E.S., Maggini S., Hornig D.H. Immune-enhancing role of Vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85&#x2013;94. doi: 10.1159/000090495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000090495</ArticleId><ArticleId IdType="pubmed">16373990</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A.C., Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1&#x2013;25. doi: 10.3390/nu9111211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111211</ArticleId><ArticleId IdType="pmc">PMC5707683</ArticleId><ArticleId IdType="pubmed">29099763</ArticleId></ArticleIdList></Reference><Reference><Citation>Fashner J., Ericson K., Werner S. Treatment of the common cold in children and adults. Am Fam Physician. 2012;86(2):153&#x2013;159. &#x3008;http://www.aafp.org/afp/2012/0715/p153.html&#x3009;</Citation><ArticleIdList><ArticleId IdType="pubmed">22962927</ArticleId></ArticleIdList></Reference><Reference><Citation>Schloss J., Lauche R., Harnett J., et al. Advances in integrative medicine efficacy and safety of vitamin C in the management of acute respiratory infection and disease: a rapid review. Adv Integr Med. 2020;7(4):187&#x2013;191. doi: 10.1016/j.aimed.2020.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aimed.2020.07.008</ArticleId><ArticleId IdType="pmc">PMC7393036</ArticleId><ArticleId IdType="pubmed">32837893</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan S., Patel K., Desai R., et al. Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia. J Clin Anesth. 2020;67:110005. doi: 10.1016/j.jclinane.2020.110005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2020.110005</ArticleId><ArticleId IdType="pmc">PMC7369577</ArticleId><ArticleId IdType="pubmed">32707517</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley R., Schloss J., Brown D., Celis D., Finnell J. The effects of vitamin D on acute viral respiratory infections: a rapid review. Adv Integr Med. 2020;7(4):192&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397989</ArticleId><ArticleId IdType="pubmed">32837896</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant W.B., Lahore H., Mcdonnell S.L., et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231123</ArticleId><ArticleId IdType="pubmed">32252338</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Ho L.P., Kalimuddin S., et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) Nutrition. 2020;79&#x2013;80:111017. doi: 10.1016/j.nut.2020.111017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.111017</ArticleId><ArticleId IdType="pmc">PMC7832811</ArticleId><ArticleId IdType="pubmed">33039952</ArticleId></ArticleIdList></Reference><Reference><Citation>Entrenas Castillo M., Entrenas Costa L.M., Vaquero Barrios J.M., Alcal&#xe1; D&#xed;az J.F., L&#xf3;pez Miranda J., Bouillon R.Q.G.J. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020 doi: 10.1016/j.jsbmb.2020.105751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2020.105751</ArticleId><ArticleId IdType="pmc">PMC7456194</ArticleId><ArticleId IdType="pubmed">32871238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohaegbulam K.C., Swalih M., Patel P., Smith M.A., Perrin R. Vitamin D supplementation in COVID-19 patients: a clinical case series. Am J Ther. 2020;27(5):e485&#x2013;e490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473790</ArticleId><ArticleId IdType="pubmed">32804682</ArticleId></ArticleIdList></Reference><Reference><Citation>Goddek S. Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate. Int J Infect Dis. 2020;99:286&#x2013;290. doi: 10.1016/j.ijid.2020.07.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.07.080</ArticleId><ArticleId IdType="pmc">PMC7406600</ArticleId><ArticleId IdType="pubmed">32768697</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Das R.R. Zinc for the common cold. Cochrane Database Syst Rev. 2015;2015(4) doi: 10.1002/14651858.CD001364.pub5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001364.pub5</ArticleId><ArticleId IdType="pmc">PMC6457799</ArticleId><ArticleId IdType="pubmed">25924708</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan G., Arroll B. Prevention and treatment of the common cold: making sense of the evidence. Can Med Assoc J. 2014;186(3):190&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928210</ArticleId><ArticleId IdType="pubmed">24468694</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlucci P.M., Ahuja T., Petrilli C., Rajagopalan H., Jones S., Rahimian J. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients. J Med Microbiol. 2020;69:1228&#x2013;1234. doi: 10.1099/jmm.0.001250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001250</ArticleId><ArticleId IdType="pmc">PMC7660893</ArticleId><ArticleId IdType="pubmed">32930657</ArticleId></ArticleIdList></Reference><Reference><Citation>Jothimani D., Kailasam E., Danielraj S., Nallathambi B. COVID-19: poor outcomes in patients with zinc deficiency. Int J Infect Dis. 2020;100:343&#x2013;349. doi: 10.1016/j.ijid.2020.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.014</ArticleId><ArticleId IdType="pmc">PMC7482607</ArticleId><ArticleId IdType="pubmed">32920234</ArticleId></ArticleIdList></Reference><Reference><Citation>BourBour F., Mirzaei Dahka S., Gholamalizadeh M., et al. Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus. Arch Physiol Biochem. 2020:1&#x2013;10. doi: 10.1080/13813455.2020.1791188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13813455.2020.1791188</ArticleId><ArticleId IdType="pubmed">32644876</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegra A., Tonacci A., Pioggia G., Musolino C., Gangemi S. Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis. Eur Rev Med Pharmacol Sci. 2020;24:9721&#x2013;9738.</Citation><ArticleIdList><ArticleId IdType="pubmed">33015818</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Wu K., Li Y., et al. Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19. Aging. 2020;12(15):15784&#x2013;15796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467385</ArticleId><ArticleId IdType="pubmed">32805728</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorino S., Gallo C., Zippi M., Sabbatani S., Manfredi R., Moretti R. Cytokine storm in aged people with CoV&#x2011;2: possible role of vitamins as therapy or preventive strategy. Aging Clin Exp Res. 2020;32(10):2115&#x2013;2131. doi: 10.1007/s40520-020-01669-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01669-y</ArticleId><ArticleId IdType="pmc">PMC7456763</ArticleId><ArticleId IdType="pubmed">32865757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Whitcroft K.L., Rueter G., Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol. 2017;274(7):2819&#x2013;2825. doi: 10.1007/s00405-017-4576-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-017-4576-x</ArticleId><ArticleId IdType="pubmed">28434127</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaimat A.N., Aolymat I., Al-holy M., et al. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Sci Food. 2020;4:17. doi: 10.1038/s41538-020-00078-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41538-020-00078-9</ArticleId><ArticleId IdType="pmc">PMC7536434</ArticleId><ArticleId IdType="pubmed">33083549</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan K.L., Kim M.V., Iwasaki A., Kasper D.L. Commensal microbiota modulation of natural resistance to virus infection. Cell. 2020;183(5):1312&#x2013;1324. doi: 10.1016/j.cell.2020.10.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.047</ArticleId><ArticleId IdType="pmc">PMC7799371</ArticleId><ArticleId IdType="pubmed">33212011</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinde T., Hansbro P., Singh Sohal S., Dingle P., Eri R., Standley R. Microbiota modulating nutritional approaches to countering the effects of viral respiratory infections including SARS-CoV-2 through promoting metabolic and immune fitness with probiotics and plant bioactives. Microorganisms. 2020;8(921):1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355654</ArticleId><ArticleId IdType="pubmed">32570850</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar F., Altayb H.N., Al-Abbasi F.A., Al-Malki A.L., Kamal M.A. Antiviral effects of probiotic metabolites on COVID-19. J Biomol Struct Dyn. 2020;39(11):4175&#x2013;4184. doi: 10.1080/07391102.2020.1775123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1775123</ArticleId><ArticleId IdType="pmc">PMC7298884</ArticleId><ArticleId IdType="pubmed">32475223</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S.K., Dicks L., Popov I.V., et al. Probiotics at war against viruses: what is missing from the picture? Front Microbiol. 2020;11:1877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7468459</ArticleId><ArticleId IdType="pubmed">32973697</ArticleId></ArticleIdList></Reference><Reference><Citation>Danilets M.G., Bel&#x2019;ski&#x12d; I., Gur&#x2019;ev A.M., et al. Effect of plant polysaccharides on Th1-dependent immune response: screening investigation. Eksp i Klin Farmakol. 2010;73(6):19&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20726346</ArticleId></ArticleIdList></Reference><Reference><Citation>Gierlikowska B., Gierlikowski W., Demkow U. Alantolactone enhances the phagocytic properties of human macrophages and modulates their proinflammatory functions. Front Pharmacol. 2020;11:1&#x2013;13. doi: 10.3389/fphar.2020.01339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01339</ArticleId><ArticleId IdType="pmc">PMC7494907</ArticleId><ArticleId IdType="pubmed">33013371</ArticleId></ArticleIdList></Reference><Reference><Citation>Gierlikowska B., Gierlikowski W., Bekier K., Skalicka-Wo&#x17a;niak K., Czerwi&#x144;ska M.E., Kiss A.K. Inula helenium and Grindelia squarrosa as a source of compounds with anti-inflammatory activity in human neutrophils and cultured human respiratory epithelium. J Ethnopharmacol. 2020;249(September 2019) doi: 10.1016/j.jep.2019.112311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.112311</ArticleId><ArticleId IdType="pubmed">31644941</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C. bo, Tian L., Yang B., Zhou H. yan. Isoalantolactone protects LPS-induced acute lung injury through Nrf2 activation. Microb Pathog. 2018;123:213&#x2013;218. doi: 10.1016/j.micpath.2018.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2018.07.010</ArticleId><ArticleId IdType="pubmed">30009971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Wang K., Gao X., Zhao K., Chen H., Xu M. Anti-inflammatory effects of isoalantolactone on LPS-stimulated BV2 microglia cells through activating GSK-3&#x3b2;-Nrf2 signaling pathway. Int Immunopharmacol. 2018;65(October):323&#x2013;327. doi: 10.1016/j.intimp.2018.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2018.10.008</ArticleId><ArticleId IdType="pubmed">30343259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzio E.A., Li N., Bauer D., et al. Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis. BMC Complement Alter Med. 2016;16(1):467. doi: 10.1186/s12906-016-1429-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-016-1429-x</ArticleId><ArticleId IdType="pmc">PMC5111180</ArticleId><ArticleId IdType="pubmed">27846826</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen K., Sparks J., Omoruyi F.O. Investigation of the cytotoxicity, antioxidative and immune-modulatory effects of Ligusticum porteri (Osha) root extract on human peripheral blood lymphocytes. J Integr Med. 2016;14(6):465&#x2013;472. doi: 10.1016/S2095-4964(16)60280-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2095-4964(16)60280-7</ArticleId><ArticleId IdType="pubmed">27854198</ArticleId></ArticleIdList></Reference><Reference><Citation>Signer J., Jonsdottir H.R., Albrich W.C., et al. In vitro virucidal activity of Echinaforce&#xae;, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. Virol J. 2020;17(1):172. doi: 10.1186/s12985-020-01439-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01439-2</ArticleId><ArticleId IdType="pmc">PMC7649903</ArticleId><ArticleId IdType="pubmed">33168000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugraha R.V., Ridwansyah H., Ghozali M., Khairani A.F., Atik N. Traditional herbal medicine candidates as complementary treatments for COVID-19: a review of their mechanisms, pros and cons. Evid-Based Complement Alter Med. 2020:2560645. doi: 10.1155/2020/2560645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2560645</ArticleId><ArticleId IdType="pmc">PMC7569437</ArticleId><ArticleId IdType="pubmed">33101440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensel A., Bauer R., Heinrich M., et al. Challenges at the time of COVID-19: Opportunities and innovations in antivirals from nature. Planta Med. 2020;86(10):659&#x2013;664. doi: 10.1055/a-1177-4396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1177-4396</ArticleId><ArticleId IdType="pmc">PMC7356065</ArticleId><ArticleId IdType="pubmed">32434254</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalifa S.A.M., Yosri N., El-mallah M.F., Ghonaim R. Screening for natural and derived bio-active compounds in preclinical and clinical studies: one of the frontlines of fighting the coronaviruses pandemic. Phytomedicine. 2020;85 doi: 10.1016/j.phymed.2020.153311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2020.153311</ArticleId><ArticleId IdType="pmc">PMC7455571</ArticleId><ArticleId IdType="pubmed">33067112</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucoin M., Cooley K., Saunders P.R., Car&#xe8; J. The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: a rapid review. Adv Integr. 2020;7(4):203&#x2013;217. doi: 10.1016/j.aimed.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aimed.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7395221</ArticleId><ArticleId IdType="pubmed">32837894</ArticleId></ArticleIdList></Reference><Reference><Citation>Silveira D., Prieto-Garcia J.M., Boylan F., et al. COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? Front Pharm. 2020;11(September):581840. doi: 10.3389/fphar.2020.581840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.581840</ArticleId><ArticleId IdType="pmc">PMC7542597</ArticleId><ArticleId IdType="pubmed">33071794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostalova D., Bukovsky M., Koscova H., Kardosova A. Anticomplement activity of Mahonia aquifolium bisbenzylisoquinoline alkaloids and berberine extract. Ces Slov Farm. 2001;50(6):286&#x2013;289. &#x3008;http://www.ncbi.nlm.nih.gov/pubmed/11797199&#x3009;</Citation><ArticleIdList><ArticleId IdType="pubmed">11797199</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreicu&#x21b; A.D., Fischer-Fodor E., P&#xe2;rvu A.E., et al. Antitumoral and immunomodulatory effect of Mahonia aquifolium extracts. Oxid Med Cell Longev. 2019;2019:6439021. doi: 10.1155/2019/6439021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/6439021</ArticleId><ArticleId IdType="pmc">PMC6948282</ArticleId><ArticleId IdType="pubmed">31949880</ArticleId></ArticleIdList></Reference><Reference><Citation>Cernakova M., Ko&#x161;&#x165;&#xe1;lov&#xe1; D. Antimicrobial activity of berberine - a constituent of Mahonia aquifolium. Folia Microbiol. 2002;47(4):375&#x2013;378. doi: 10.1007/BF02818693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02818693</ArticleId><ArticleId IdType="pubmed">12422513</ArticleId></ArticleIdList></Reference><Reference><Citation>Slobodn&#xed;kov&#xe1; L., Ko&#x161;t&#x2019;&#xe1;lov&#xe1; D., Labudov&#xe1; D., Kotulov&#xe1; D., Kettmann V. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phyther Res. 2004;18(8):674&#x2013;676. doi: 10.1002/ptr.1517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.1517</ArticleId><ArticleId IdType="pubmed">15476315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper I.D., Crofts C.A.P., DiNicolantonio J.J., et al. Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management. Open Hear. 2020;7(2) doi: 10.1136/openhrt-2020-001356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2020-001356</ArticleId><ArticleId IdType="pmc">PMC7496570</ArticleId><ArticleId IdType="pubmed">32938758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace T. Combating COVID-19 and building immune resilience: a potential role for magnesium nutrition? J Am Coll Nutr. 2020;39(8):685&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">32649272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Ho L.P., Kalimuddin S., et al. Cohort study to evaluate effect of vitamin D, magnesium, and vitamin B12 in combination on severe outcome progression in older patients with coronavirus (COVID-19) Nutrition. 2020;79&#x2013;80:111017. doi: 10.1016/j.nut.2020.111017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.111017</ArticleId><ArticleId IdType="pmc">PMC7832811</ArticleId><ArticleId IdType="pubmed">33039952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiedra R., Lo K.B., Elbashabsheh M., et al. The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther. 2020;18(12):1259&#x2013;1261. doi: 10.1080/14787210.2020.1794819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2020.1794819</ArticleId><ArticleId IdType="pmc">PMC7441798</ArticleId><ArticleId IdType="pubmed">32662690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Ling Y., Li J., et al. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study. Ann Palliat Med. 2021;10(2):1599&#x2013;1609. doi: 10.21037/apm-20-1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-1387</ArticleId><ArticleId IdType="pubmed">33222462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura J., Kubota K., Murakami H., et al. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999;116(1):28&#x2013;32. doi: 10.1046/j.1365-2249.1999.00870.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.1999.00870.x</ArticleId><ArticleId IdType="pmc">PMC1905232</ArticleId><ArticleId IdType="pubmed">10209501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan S., Basford R.E. Effect of vitamin B12 and folic acid deficiencies on neutraphil function. Blood. 1976;47(5):801&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">1260135</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan N., Nair D.T. Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus. IUBMB Life. 2020;72(10):2112&#x2013;2120. doi: 10.1002/iub.2359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2359</ArticleId><ArticleId IdType="pmc">PMC7461454</ArticleId><ArticleId IdType="pubmed">32812340</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera M., El Khoury J., Chinni V., et al. Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol. BMJ Open. 2020;10(12) doi: 10.1136/bmjopen-2020-040580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040580</ArticleId><ArticleId IdType="pmc">PMC7712927</ArticleId><ArticleId IdType="pubmed">33268419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumrungsee T., Zhang P., Chartkul M., Yanaka N., Kato N. Potential role of vitamin B6 in ameliorating the severity of COVID-19 and its complications. Front Nutr. 2020;7(October):1&#x2013;5. doi: 10.3389/fnut.2020.562051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2020.562051</ArticleId><ArticleId IdType="pmc">PMC7658555</ArticleId><ArticleId IdType="pubmed">33195363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeff J.L., Snider P., Myers S.P., DeGrandpre Z. A Hierarchy of Healing: The Therapeutic Order. Fourth ed. Elsevier; 2013.</Citation></Reference><Reference><Citation>Rothman K., Moore L., Singer M., Nguyen U., Mannino S., Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369&#x2013;1373.</Citation><ArticleIdList><ArticleId IdType="pubmed">7477116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein N., Akram M., Yaniv-Bachrach Z., Daniyal M. Is it safe to consume traditional medicinal plants during pregnancy? Phyther Res. 2021;35:1908&#x2013;1924. doi: 10.1002/ptr.6935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6935</ArticleId><ArticleId IdType="pubmed">33164294</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinker F. Herb Contraindications and Drug Interactions. Third Edit. (Stodart N., ed.). Eclectic Medical Publications; 2001.</Citation></Reference><Reference><Citation>Carsetti R., Zaffina S., Piano Mortari E., et al. Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases. Front Immunol. 2020;11:610300. doi: 10.3389/fimmu.2020.610300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.610300</ArticleId><ArticleId IdType="pmc">PMC7772470</ArticleId><ArticleId IdType="pubmed">33391280</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E., Reynolds G., Botting R.A., et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27:904&#x2013;916. doi: 10.1038/s41591-021-01329-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01329-2</ArticleId><ArticleId IdType="pmc">PMC8121667</ArticleId><ArticleId IdType="pubmed">33879890</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanuck S., Pizzorno J., Messier H., Fitzgerald K. Evidence supporting a phased immuno-physiological approach to COVID-19 from prevention through recovery. Integr Med A Clin J. 2020;19:8&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190003</ArticleId><ArticleId IdType="pubmed">32425712</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Lewis E.D., Pae M., Meydani S.N. Nutritional modulation of immune function: analysis of evidence, mechanisms, and clinical relevance. Front Immunol. 2019;9(January):1&#x2013;19. doi: 10.3389/fimmu.2018.03160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03160</ArticleId><ArticleId IdType="pmc">PMC6340979</ArticleId><ArticleId IdType="pubmed">30697214</ArticleId></ArticleIdList></Reference><Reference><Citation>Im J.H., Je Y.S., Baek J., Chung M.H., Kwon H.Y., Lee J.S. Nutritional status of patients with COVID-19. Int J Infect Dis. 2020;100:390&#x2013;393. doi: 10.1016/j.ijid.2020.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.018</ArticleId><ArticleId IdType="pmc">PMC7418699</ArticleId><ArticleId IdType="pubmed">32795605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi R.T., Lynch J.B., del Rio C. Mild or moderate Covid-19. N Engl J Med. 2020;383(18):1757&#x2013;1766. doi: 10.1056/nejmcp2009249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmcp2009249</ArticleId><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Galm&#xe9;s S., Serra F., Palou A. Current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework. Nutrients. 2020;12(9):2738. doi: 10.3390/nu12092738.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12092738</ArticleId><ArticleId IdType="pmc">PMC7551697</ArticleId><ArticleId IdType="pubmed">32911778</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik P.E., Kory P., Varon J., Iglesias J., Meduri G.U. MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale. Expert Rev Anti Infect Ther. 2021;19(2):129&#x2013;135. doi: 10.1080/14787210.2020.1808462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2020.1808462</ArticleId><ArticleId IdType="pubmed">32809870</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Tian M., Zeng Y., et al. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19. Complement Ther Med. 2020;52 doi: 10.1016/j.ctim.2020.102473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctim.2020.102473</ArticleId><ArticleId IdType="pmc">PMC7282787</ArticleId><ArticleId IdType="pubmed">32951723</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Chen X., Lu Y., Chen F., Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020;14(1):64&#x2013;68. doi: 10.5582/bst.2020.01030.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2020.01030</ArticleId><ArticleId IdType="pubmed">32037389</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.B., Wang Z.X., Jing J., et al. Exploring an integrative therapy for treating COVID-19: a randomized controlled trial. Chin J Integr Med. 2020;26(9):648&#x2013;655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7364292</ArticleId><ArticleId IdType="pubmed">32676976</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik P.. EVMS Critical Care COVID-19 Management Protocol; 2020. &#x3008;https://www.evms.edu/covid-19/&#x3009;.</Citation></Reference><Reference><Citation>Alschuler L., Weil A., Horwitz R., et al. Integrative considerations during the COVID-19 pandemic. EXPLORE. 2020;16(6):354&#x2013;356. doi: 10.1016/j.explore.2020.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.explore.2020.03.007</ArticleId><ArticleId IdType="pmc">PMC7270871</ArticleId><ArticleId IdType="pubmed">32229082</ArticleId></ArticleIdList></Reference><Reference><Citation>Alschuler L., Chiasson A.M., Horwitz R., et al. Integrative medicine considerations for convalescence from mild-to- moderate COVID-19 disease. EXPLORE. 2020:S1550&#x2013;8307&#x2013;1. doi: 10.1016/j.explore.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.explore.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7756157</ArticleId><ArticleId IdType="pubmed">33358750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kory P., Meduri G.U., Iglesias J., Varon J., Marik P.E. Clinical and scientific rationale for the &#x201c;MATH+&#x201d; hospital treatment protocol for COVID-19. J Intensive Care Med. 2021;36(2):135&#x2013;156. doi: 10.1177/0885066620973585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066620973585</ArticleId><ArticleId IdType="pubmed">33317385</ArticleId></ArticleIdList></Reference><Reference><Citation>Girija P.L.T., Sivan N. Ayurvedic treatment of COVID-19/SARS-CoV-2: a case report. J Ayurveda Integr Med. 2021:1&#x2013;5. doi: 10.1016/j.jaim.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7303645</ArticleId><ArticleId IdType="pubmed">32680602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A., Bentur S.A., Thakral S., Garg R., Duggal B. The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high&#x2011;risk case of COVID &#x2011; 19/SARS&#x2011;CoV&#x2011;2 with multiple comorbidities: a case report. J Med Case Rep. 2021;15(1):95. doi: 10.1186/s13256-020-02624-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-020-02624-1</ArticleId><ArticleId IdType="pmc">PMC7903378</ArticleId><ArticleId IdType="pubmed">33627186</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi J., Puthiyedath R. Outcomes of Ayurvedic care in a COVID-19 patient with hypoxia - A case report. J Ayurveda Integr Med. 2020 doi: 10.1016/j.jaim.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7553124</ArticleId><ArticleId IdType="pubmed">33071521</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sayed S.M., Aboonq M.S., Aljehani Y.T., et al. TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic. Am J Blood Res. 2020;10(6):397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7811903</ArticleId><ArticleId IdType="pubmed">33489449</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Zhu Y., Zhang J., Li Y., Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. Br Med J. 2020;10(7):e039519. doi: 10.1136/bmjopen-2020-039519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039519</ArticleId><ArticleId IdType="pmc">PMC7348463</ArticleId><ArticleId IdType="pubmed">32641343</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>